STOCK TITAN

electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

electroCore (Nasdaq: ECOR) will report third quarter results for the period ended September 30, 2025 after market close on Wednesday, November 5, 2025. Management will host a results webinar on November 5, 2025 at 4:30 PM EST to review the financial results and answer questions.

Investors can join via dial-in (646) 931-3860, Webinar ID 822 9598 1338, passcode 454695, or register using the provided registration link to participate and ask questions.

electroCore (Nasdaq: ECOR) riporterà i risultati del terzo trimestre per il periodo terminato 30 settembre 2025 dopo la chiusura del mercato di mercoledì 5 novembre 2025. Il management terrà un webinar sui risultati il 5 novembre 2025 alle ore 16:30 EST per esaminare i risultati finanziari e rispondere alle domande.

Gli investitori possono partecipare mediante chiamata dial-in (646) 931-3860, Webinar ID 822 9598 1338, codice d'accesso 454695, oppure registrarsi tramite il link di registrazione fornito per partecipare e porre domande.

electroCore (Nasdaq: ECOR) reportará los resultados del tercer trimestre correspondientes al periodo terminado 30 de septiembre de 2025 después del cierre del mercado el miércoles 5 de noviembre de 2025. La dirección realizará un seminario web de resultados el 5 de noviembre de 2025 a las 4:30 PM EST para revisar los resultados financieros y responder preguntas.

Los inversores pueden unirse por dial-in (646) 931-3860, ID de Webinar 822 9598 1338, código de acceso 454695, o registrarse mediante el enlace de registro proporcionado para participar y hacer preguntas.

electroCore (나스닥: ECOR)2025년 9월 30일 종료된 기간에 대한 3분기 실적을 2025년 11월 5일 수요일 장 마감 후 발표합니다. 경영진은 2025년 11월 5일 오후 4:30 EST에 실적 웨비나를 주최하여 재무 결과를 검토하고 질문에 답합니다.

투자자들은 전화 접속 번호 (646) 931-3860, 웨비나 ID 822 9598 1338, 비밀번호 454695를 통해 참여하거나 제공된 등록 링크를 사용하여 등록하고 질문할 수 있습니다.

electroCore (Nasdaq : ECOR) publiera les résultats du deuxième/trimestre pour la période se terminant le 30 septembre 2025 après la clôture du marché le mercredi 5 novembre 2025. La direction organisera un webinaire sur les résultats le 5 novembre 2025 à 16h30 EST pour examiner les résultats financiers et répondre aux questions.

Les investisseurs peuvent rejoindre par dial-in (646) 931-3860, ID de webinaire 822 9598 1338, mot de passe 454695, ou s'inscrire via le lien d'inscription fourni pour participer et poser des questions.

electroCore (Nasdaq: ECOR) wird die Ergebnisse des dritten Quartals für den Zeitraum bis zum 30. September 2025 nach Börsenschluss am Mittwoch, dem 5. November 2025 bekannt geben. Die Geschäftsführung wird zu 5. November 2025 um 16:30 Uhr EST ein Ergebnisse-Webinar abhalten, um die finanziellen Ergebnisse zu besprechen und Fragen zu beantworten.

Investoren können sich über Einwahl unter (646) 931-3860, Webinar-ID 822 9598 1338, Passcode 454695 verbinden oder den bereitgestellten Registrierungslink verwenden, um teilzunehmen und Fragen zu stellen.

electroCore (نازداك: ECOR) ستعلن عن نتائج الربع الثالث للفترة المنتهية في 30 سبتمبر 2025 بعد اغلاق السوق يوم الأربعاء 5 نوفمبر 2025. ستستضيف الإدارة webinar للنتائج في 5 نوفمبر 2025 الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة لمراجعة النتائج المالية والرد على الأسئلة.

يمكن للمستثمرين الانضمام عبر dial-in (646) 931-3860، معرف الويبينار 822 9598 1338، رمز المرور 454695، أو التسجيل باستخدام رابط التسجيل المقدم للمشاركة وطرح الأسئلة.

electroCore (纳斯达克:ECOR) 将在 2025年9月30日结束的季度结束后,于 2025年11月5日,星期三 收盘后公布第三季度业绩。管理层将于 2025年11月5日,东部标准时间下午4:30 举行业绩网络研讨会,回顾财务业绩并回答问题。

投资者可通过拨入电话 (646) 931-3860、网络研讨会ID 822 9598 1338、访问码 454695 参与并提问,或使用提供的注册链接注册参与。

Positive
  • None.
Negative
  • None.

ROCKAWAY, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the third quarter ended September 30, 2025, after the close of the market on Wednesday, November 5, 2025.

Management will host a webinar at 4:30 PM EST to review the financial results and answer questions. Investors can access the webinar using the details below:

Wednesday, November 5, 4:30 PM EST
Dial-In: (646) 931-3860
Webinar ID: 822 9598 1338
Passcode: 454695
Registration Link: Click here to participate and ask questions on the call.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com.

Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com


FAQ

When will electroCore (ECOR) report Q3 2025 results?

electroCore will report third quarter results for the period ended September 30, 2025 after market close on November 5, 2025.

What time is the electroCore (ECOR) Q3 2025 webinar and how can I join?

The webinar is scheduled for 4:30 PM EST on November 5, 2025; join via dial-in (646) 931-3860 or Webinar ID 822 9598 1338 with passcode 454695.

How can investors register to ask questions on the electroCore (ECOR) November 5, 2025 call?

Investors can register using the provided registration link to participate and submit questions during the webinar.

Will electroCore (ECOR) management answer questions during the Q3 2025 webcast?

Yes; management will review results and answer questions during the 4:30 PM EST webinar on November 5, 2025.

What are the dial-in details for the electroCore (ECOR) Q3 2025 results call?

Dial-in: (646) 931-3860; Webinar ID: 822 9598 1338; Passcode: 454695.
Electrocore

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Latest SEC Filings

ECOR Stock Data

39.18M
5.09M
37.28%
15.51%
5.96%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
ROCKAWAY